American Psychiatric Association Practice Guideline for the Treatment of Patients with Schizophrenia

The guideline focuses specifically on evidence-based pharmacological and nonpharmacological treatments for schizophrenia and includes statements related to assessment and treatment planning, which are an integral part of patient-centered care. The guideline provides direction on implementing these recommendations into clinical practice.

La nivel mondial, schizofrenia este una dintre primele 20 de cauze ale dizabilitatii. Prevalenta schizofreniei pe viata este estimata la aproximativ 0,7%, desi constatarile variaza in functie de locatia studiului, caracteristicile demografice ale esantionului, abordarea adoptata pentru depistarea cazurilor, metoda utilizata pentru confirmarea diagnosticului si criteriile de diagnostic utilizate.